| Literature DB >> 16162098 |
Kris Denhaerynck1, Fabienne Dobbels, Irina Cleemput, Ariane Desmyttere, Petra Schäfer-Keller, Stefan Schaub, Sabina De Geest.
Abstract
This literature review summarizes the evidence on the prevalence, determinants, clinical and economic consequences of nonadherence with immunosuppressive drugs in renal transplant patients. A literature search yielded 38 articles measuring nonadherence by self-report, collateral report, assay, refill prescriptions or electronic monitoring. The weighted mean prevalence of self-reported nonadherence was 28%. Nonadherence is associated with poor clinical outcomes, contributing to 20% of late acute rejection episodes and 16% of the graft losses (weighted means). In addition, nonadherence results in lower lifetime costs because of shorter survival, yet also in a lower number of quality adjusted life years. Consistent determinants of nonadherence were younger age, social isolation, and cognitions (e.g. low self-efficacy, certain health beliefs). Determinants concerning the health care system/team seem to be under-investigated. Because the evidence summarized in this review is based on older immunosuppressive regimens, further research should focus on prevalence, determinants and consequences of nonadherence with newer immunosuppressive regimens.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16162098 DOI: 10.1111/j.1432-2277.2005.00176.x
Source DB: PubMed Journal: Transpl Int ISSN: 0934-0874 Impact factor: 3.782